Pasireotide (SOM230)

pasireotide · Novartis

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Pasireotide (SOM230), covering 2015-12-24 to 2015-12-24. Get the full timeline:

Most recent: Clinical Trial Update: Phase I Trial of Combination of FOLFIRI and SOM 230 [Phase 1]